1Itoh S,Itoh F,Goumans MJ,etal.Signaling of TGFβfamily members through Smad proteins[J].Eur J Biochem,2000,267(24):6954-6967.
2Pasche B.Role of TFGβin cancer[J].J Cell Physiol,2001,186(2):153-168.
3Miyazono K,TenDijke P,Heldin CH.TGFβsignaling by Smad proteins[J].Adv Immunol,2000,75(1):115 157.
4Woodford Richens KL,Rowan AJ,Gorman P,etal.SMAD4 mutations in colorectal cancer probably occur before chromosomal instability,but after divergence of the microsatellite instability pathway[J].Proc Natl Acad Sci USA,2001 Aug 14;98(17):9719-23.
5Zhou S,Buckhaults P,Zawel L,etal.Targeted deletion of Smad4 shows it is required for transforming growth factorbeta and activin signaling in colorectal cancer cells[J].Proc Natl Acad Sci USA,1998 Mar 3;95(5):2412-6.
6Boulay JL,Mild G,Reuter J,et al.Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of MAD7[J].Genes Chromosomes Cancer,2001 Jul; 31(3):240-7.
7Halder SK,Beauchamp RD,Datta PK.Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis[J].Exp Cell Res.2005 Jul 1;307(1):231-46.Epub 2005 Apr 19.
1Hata A,Shi Y, Massague J. TGF-beta signaling and cancer: structural and functional consequences of mutations in Smads[J]. Mol Med Today, 1998,4:257 - 62.
2Miyazono K. TGF-beta/Smad signaling and its involvement in tumor progression[ J]. Biol Pharm Bull ,2000,23:1125 - 30.
3Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions[ J]. Am J Surg Pathol,2001,25:579 - 86.
4Biankin AV, Kench JG, Biankin SA,et al. Pancreatic intraepithelial neoplasia in association with intraductal papillary mucinous neoplasms of the pancreas: implications for disease progression and recurrence[ J]. Am J Surg Pathol,2004 ,28 :1184 -92.
5Subramanian G, Schwarz RE, Higgins L, et al. Targeting endogenous transforming growth factor beta receptor signaling in Smad4deficient human pancreatic carcinoma cells inhibits their invasive phenotype1[J]. Cancer Res,2004,64:5200 -11.
6Shi Y, Hata A,Lo RS,et al. A structural basis for mutational inactivation of the tumour suppressor Smad4 [ J]. Nature, 1997,388:87 - 93.
7Tascilar M,Skinner HG,Rosty C,et al. The Smad4 protein and prognosis of pancreatic ductal adenocarcinoma [ J ]. Clin Cancer Res ,2001,7:4115 - 21.
8Kleeff J, Ishiwata T, Maruyama H, et al. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer[ J].Oncogene, 1999,18:5363 - 72.
9Maitra A, Adsay NV, Argani P, et al. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray [ J ]. Mod Pathol,2003,16:902 - 12.
